AU710113B2 - Submicron liposome suspensions obtained from preliposome lyophilizates - Google Patents

Submicron liposome suspensions obtained from preliposome lyophilizates Download PDF

Info

Publication number
AU710113B2
AU710113B2 AU61087/96A AU6108796A AU710113B2 AU 710113 B2 AU710113 B2 AU 710113B2 AU 61087/96 A AU61087/96 A AU 61087/96A AU 6108796 A AU6108796 A AU 6108796A AU 710113 B2 AU710113 B2 AU 710113B2
Authority
AU
Australia
Prior art keywords
surfactant
approximately
composition
lipid
annamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU61087/96A
Other languages
English (en)
Other versions
AU6108796A (en
Inventor
Roman Perez-Soler
Waldemar Priebe
Yiyu Zou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of AU6108796A publication Critical patent/AU6108796A/en
Application granted granted Critical
Publication of AU710113B2 publication Critical patent/AU710113B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU61087/96A 1995-06-06 1996-06-06 Submicron liposome suspensions obtained from preliposome lyophilizates Ceased AU710113B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/468,791 US5902604A (en) 1995-06-06 1995-06-06 Submicron liposome suspensions obtained from preliposome lyophilizates
US08/468791 1995-06-06
PCT/US1996/009830 WO1996039121A1 (en) 1995-06-06 1996-06-06 Submicron liposome suspensions obtained from preliposome lyophilizates

Publications (2)

Publication Number Publication Date
AU6108796A AU6108796A (en) 1996-12-24
AU710113B2 true AU710113B2 (en) 1999-09-16

Family

ID=23861262

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61087/96A Ceased AU710113B2 (en) 1995-06-06 1996-06-06 Submicron liposome suspensions obtained from preliposome lyophilizates

Country Status (6)

Country Link
US (2) US5902604A (2)
EP (2) EP0831781A1 (2)
JP (1) JPH11507369A (2)
AU (1) AU710113B2 (2)
CA (1) CA2221341C (2)
WO (1) WO1996039121A1 (2)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1045688A1 (en) * 1998-01-16 2000-10-25 Biomira Usa Inc. Lipomatrix preparation
EP1150658B1 (en) * 1999-02-08 2004-08-04 Alza Corporation Method for controlling liposome size
WO2001032145A1 (en) * 1999-10-29 2001-05-10 Board Of Regents, The University Of Texas System Method of cancer treatment
EP1138312A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
US6761901B1 (en) 2000-05-02 2004-07-13 Enzrel Inc. Liposome drug delivery
US20020007055A1 (en) * 2000-05-15 2002-01-17 Hirotaka Uchiyama Compositions comprising cyclodextrin
US8658202B2 (en) * 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
CN1245153C (zh) * 2002-06-06 2006-03-15 上海家化联合股份有限公司 一种维生素a脂质体及其制备方法
AU2003257791A1 (en) * 2002-08-15 2004-03-29 Tong Liu Soild nano pharmaceutical formulation and preparation method thereof
US20070160656A1 (en) * 2003-05-02 2007-07-12 Dziewiszek Krzysztof J Lipid platinum complexes and methods of use thereof
US20080050425A1 (en) * 2003-05-20 2008-02-28 Jonathan Lewis Combination Chemotherapy Comprising 5-Fluorouracil or a Derivative Thereof and a Liposomal Platinum Complex
AU2003239511A1 (en) * 2003-05-20 2004-12-13 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
AU2003239510A1 (en) * 2003-05-20 2005-01-21 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising gemcitabine and a liposomal platinum complex
AU2003233586A1 (en) * 2003-05-20 2005-01-21 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising capecitabine and a liposomal platinum complex
US20060222694A1 (en) * 2003-06-27 2006-10-05 Oh Choon K Stabilized topotecan liposomal composition and methods
US20060002994A1 (en) * 2004-03-23 2006-01-05 Thomas James L Responsive liposomes for ultrasonic drug delivery
CA2706923A1 (en) * 2007-11-30 2009-06-11 Endo Pharmaceuticals Solutions, Inc. Intravesical compositions with valrubicin for the treatment of bladder cancer
CN105434354A (zh) * 2009-06-03 2016-03-30 斯昆申技术控股有限责任公司 用于治疗深部组织疼痛的制剂
WO2011071860A2 (en) * 2009-12-07 2011-06-16 Alnylam Pharmaceuticals, Inc. Compositions for nucleic acid delivery
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
US9987227B2 (en) * 2013-10-22 2018-06-05 Aradigm Corporation Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
US20160120806A1 (en) * 2014-04-08 2016-05-05 Aradigm Corporation Nanocrystals formed in a microenvironment
US9532986B2 (en) 2014-04-08 2017-01-03 Aradigm Corporation Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
RU2016143591A (ru) * 2014-04-08 2018-05-08 Арадайм Корпорейшн Липосомы, в которых образуются нанокристаллы лекарственного вещества после замораживания-оттаивания
ES2879383T3 (es) 2015-06-30 2021-11-22 Sequessome Tech Holdings Limited Fórmulas mixtas
MY198105A (en) * 2016-01-07 2023-08-02 Univ Western Health Sciences Formulations for treating bladder cancer
KR102579836B1 (ko) 2016-12-22 2023-09-15 제넨테크, 인크. 동결건조된 폴리펩타이드의 재구성 시간을 감소시키기 위한 방법 및 제제
US20200188298A1 (en) * 2018-12-14 2020-06-18 NuVessl, Inc. Method For Using Composition With Enhanced Passenger Molecule Loading
WO2020264161A1 (en) * 2019-06-28 2020-12-30 Donald Picker Method of reconstituting liposomal annamycin
EP3989978B1 (en) * 2019-06-28 2025-12-17 Board of Regents, The University of Texas System Preparation of preliposomal annamycin lyophilizate
AU2020386092A1 (en) 2019-11-21 2022-06-16 Board Of Regents, The University Of Texas System Lung targeted anticancer therapies with liposomal annamycin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
US4201773A (en) * 1978-07-26 1980-05-06 The United States Of America As Represented By The Department Of Health, Education And Welfare 7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
BG38660A1 (en) * 1983-01-11 1986-02-14 Petkov Machine for hydroplastic processing of tube items
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
JPS60155109A (ja) * 1984-01-23 1985-08-15 Terumo Corp リポソ−ム製剤
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same
CA1264668A (en) * 1984-06-20 1990-01-23 Pieter R. Cullis Extrusion techniques for producing liposomes
ZW3385A1 (en) * 1985-03-01 1986-09-24 David John Fluck Liposomes,process for their preparation and compositions containing them
US4975282A (en) * 1985-06-26 1990-12-04 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
GB8516859D0 (en) 1985-07-03 1985-08-07 Secretary Trade Ind Brit Cam follower mechanisms
DE3689769T2 (de) * 1985-07-05 1994-07-21 Liposome Co Inc Multilamellare liposome mit verbesserter einschliessungswirkung.
JPS6295134A (ja) * 1985-10-21 1987-05-01 Nippon Saafuakutanto Kogyo Kk リポソ−ムの製造法
US4812312A (en) * 1987-03-03 1989-03-14 Board Of Regents Of The University Of Texas System Liposome-incorporated nystatin
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US4855090A (en) * 1987-03-13 1989-08-08 Micro-Pak, Inc. Method of producing high aqueous volume multilamellar vesicles
US4863739A (en) * 1987-05-19 1989-09-05 Board Of Regents, The University Of Texas System Liposome compositions of anthracycline derivatives
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
US4950432A (en) * 1987-10-16 1990-08-21 Board Of Regents, The University Of Texas System Polyene microlide pre-liposomal powders
JPH03502327A (ja) * 1988-01-19 1991-05-30 ボード・オブ・リージェンツ，ザ・ユニバーシティ・オブ・テキサス・システム ３’‐デアミノドキソルビシンのエステル体、そのリポソーム組成物およびその使用方法
CA1335077C (en) * 1988-02-08 1995-04-04 Henri Isliker Process for the manufacture of apolipoproteins from human blood plasma or serum
CA1340241C (en) * 1988-06-08 1998-12-15 Fountain Pharmaceuticals, Inc. Method for marking solvent dilution microcarriers
US4999199A (en) * 1988-11-10 1991-03-12 Board Of Regents, The University Of Texas System Pharmaceutical formulations: liposomes incorporating aromatic polyene antibiotics
US5032404A (en) * 1989-02-23 1991-07-16 Board Of Regents, The University Of Texas System Lipsome-incorporation of polyenes
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
JPH06183953A (ja) * 1991-06-24 1994-07-05 Nippon Oil & Fats Co Ltd 混合脂質膜小胞
JPH06293615A (ja) * 1992-08-25 1994-10-21 Nippon Oil & Fats Co Ltd 混合脂質膜小胞を含有する化粧品
JPH06227966A (ja) * 1993-01-29 1994-08-16 Advanced Sukin Res Kenkyusho:Kk 温度感受性リポソーム製剤
FR2700954B1 (fr) * 1993-01-29 1995-04-28 Eve International Sa Composition cosmétique à action réparatrice et protectrice des cheveux secs et très secs.
DE4306475A1 (de) * 1993-03-02 1994-09-08 Ensenat Pedro Gonzalez Liposomen, enthaltend Chlorhexidindiacetat oder Chlorhexidindigluconat
JPH08512056A (ja) * 1993-06-30 1996-12-17 ジェネンテク・インコーポレイテッド リポソームの製造法
US5820880A (en) * 1995-06-07 1998-10-13 The United States Of America As Represented By The Secretary Of The Army Liposomal formulation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation

Also Published As

Publication number Publication date
JPH11507369A (ja) 1999-06-29
EP1800665A3 (en) 2008-06-04
EP1800665A2 (en) 2007-06-27
CA2221341C (en) 2009-04-21
AU6108796A (en) 1996-12-24
US5902604A (en) 1999-05-11
EP0831781A1 (en) 1998-04-01
CA2221341A1 (en) 1996-12-12
WO1996039121A1 (en) 1996-12-12
US7238366B1 (en) 2007-07-03

Similar Documents

Publication Publication Date Title
US5902604A (en) Submicron liposome suspensions obtained from preliposome lyophilizates
Mayhew et al. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid
JP2882607B2 (ja) リポソーム性抗腫瘍剤の高薬剤：脂質調剤
Storm et al. Liposomes: quo vadis?
EP0219922B1 (en) Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
US4877619A (en) Liposomal vesicles for intraperitoneal administration of therapeutic agents
AU717181B2 (en) Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
JP2958774B2 (ja) アンホテリシンｂリポソームの改良調整法
EP0380584B1 (en) Polyene macrolide pre-liposomal powders
WO1994026254A1 (en) Incorporation of taxol into liposomes and gels
WO1987001933A1 (en) Stabilized liposome/amphotericin composition and method
US20080279927A1 (en) Non-Pegylated Long-Circulating Liposomes
CN1044093C (zh) 低毒性药物类脂制剂
JP2677576B2 (ja) 非水溶性の有効成分のためのリン脂質輪送ビヒクル
CA2202103C (en) Method for preparing closed vesicles
JP2006510674A (ja) 脂質：エモジン製剤に関する組成物および方法
CA2511464C (en) Non-pegylated long-circulating liposomes
JP2022538865A (ja) リポソーム化アナマイシン前駆体凍結乾燥物の調製
MXPA05002183A (es) Una composicion farmaceutica de liposomas de tamano pequeno y metodo de preparacion.
Zou et al. Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size
JP3693209B2 (ja) 閉鎖小胞の製造方法
Hasan et al. Liposomes: an advance tools for novel drug delivery system
JP2002509866A (ja) リポソーム様作用物質調剤の製造法
JPH06502623A (ja) 安定なドキソルビシン／リポソーム組成物
WO2020254633A1 (en) Liposomal doxorubicin formulation, method for producing a liposomal doxorubicin formulation and use of a liposomal doxorubicin formulation as a medicament